Residual Disease Activity and Burden of Disease in Canadian Patients With Axial Spondyloarthritis: Results From a Multiregistry Analysis (UNISON-Axial SpA)

This analysis demonstrated that most Canadians with axSpA failed to achieve sustained LDA after 12 months of initiating their latest therapy and confirms a high unmet need for additional treatments.

Authors

Institutions

Publication Details

Journal
The Journal of Rheumatology
Published
2025-07-01
DOI
https://doi.org/10.3899/jrheum.2024-1303
Citations
2
Primary Topic
Spondyloarthritis Studies and Treatments
Type
article
Field-Weighted Citation Impact
3.34

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Residual Disease Activity and Burden of Disease in Canadian Patients With Axial Spondyloarthritis: Results From a Multiregistry Analysis (UNISON-Axial SpA)

Marie-Claude Laliberté, Sibel Zehra Aydın, Stephanie A. Wichuk, Robert D. Inman et al.
2 citations
The Journal of Rheumatology
Spondyloarthritis Studies and Treatments
3.34
article

Residual Disease Activity and Burden of Disease in Canadian Patients With Axial Spondyloarthritis: Results From a Multiregistry Analysis (UNISON-Axial SpA)

Marie-Claude Laliberté, Sibel Zehra Aydın, Stephanie A. Wichuk, Robert D. Inman, Pierre‐André Fournier, Tanya Girard, Dafna D. Gladman, Sherry Rohekar, Michael Starr, Proton Rahman, D. Choquette, Walter P. Maksymowych, Jonathan Chan, Olga Ziouzina, Alexander Tsoukas, Michel Zummer, Nicolas Richard, Louis Coupal, Vinod Chandran, Tristan Boyd, Dianne Mosher, Carter Thorne
article en
2 citations

Abstract

This analysis demonstrated that most Canadians with axSpA failed to achieve sustained LDA after 12 months of initiating their latest therapy and confirms a high unmet need for additional treatments.

The Journal of RheumatologyVol. 52(11)
Memorial University of Newfoundland (CA), University Health Network (CA), University of Alberta (CA), University of Calgary (CA), Montreal Heart Institute (CA), Ottawa Hospital (CA), McGill University Health Centre (CA), SNC-Lavalin (Canada) (CA), Alberta Energy (CA), Hôpital Maisonneuve-Rosemont (CA), Canadian Rheumatology Association (CA), ABB (Canada) (CA), Arthritis Research Centre of Canada (CA), St Joseph's Health Care (CA), Krembil Research Institute, McGill University (CA), St. Joseph’s Healthcare Hamilton (CA), Université de Montréal (CA)
Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Celgene, Canadian Institutes of Health Research
Good health and well-being
Openalex Percentile: Top 8%
Spondyloarthritis Studies and Treatments
3.34
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.